| 000 | 01124nam a2200241 a 4500 | ||
|---|---|---|---|
| 999 |
_c677 _d677 |
||
| 003 | AR-BaISA | ||
| 005 | 20191016113803.0 | ||
| 007 | ta | ||
| 008 | 191016s2019 sz ||||| |||| 00| 0 eng d | ||
| 020 | _a9789291620487 | ||
| 040 | _cAR-BaISA | ||
| 041 | 1 | _aeng | |
| 082 | 0 | 4 |
_222 _a346.048 V541 |
| 100 | 1 | 0 |
_91633 _aVelásquez, Germán _eaut. |
| 245 | 1 | 0 |
_aSeeking remedies for access to medicines and intellectual property: _brecent developments / _cGermán Velásquez |
| 260 |
_aGinebra: _bSouth Centre, _c2019 |
||
| 300 | _aXI, 174 p. | ||
| 504 | _aBibliografía p.: 169-174 | ||
| 505 |
_tGuidelines on patentability and access to medicines -- _tThe international debate on generic medicines of biological origin -- _tAccess to hepatitis C treatment: a global problem -- _tIntellectual property, public health and access to medicines in international organizations -- _tAccess to medicines: experiences with compulsory licenses and goverment use - the case of hepatitis C |
||
| 650 | 1 | 4 |
_91634 _aPatentes de medicamentos |
| 650 | 1 | 4 |
_9194 _aPropiedad intelectual de productos y procesos farmacéuticos |
| 942 |
_2ddc _cLI |
||